Active ingredientFimasartanCat. No. P-F046-001CAS 247257-48-3Family · Pharmaceutical analytical standards
Fimasartan
An angiotensin II receptor blocker (sartan) developed in South Korea, where it was approved in September 2010 for the treatment of hypertension. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It was the ninth sartan to be developed: it derives from losartan, with its imidazole ring replaced by a pyrimidinone ring.
Go to the active ingredient →Active ingredientFimasartanCat. No. P-F046-001CAS 247257-48-3
Isotopically labelledFimasartan-d6Cat. No. P-F046-002
ImpurityFimasartan Impurity 1 (Mixture of J and K)Cat. No. P-F046-003
ImpurityFimasartan Impurity 2Cat. No. P-F046-004CAS 1361024-52-3
ImpurityFimasartan Impurity 3Cat. No. P-F046-006No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.